Ery-tab

— THERAPEUTIC CATEGORIES —
  • Bacterial infections

Ery-tab Generic Name & Formulations

General Description

Erythromycin (as base) 250mg, 333mg, 500mg; e-c tabs.

Pharmacological Class

Macrolide.

How Supplied

250mg—30, 40, 100, 500; 333mg—30, 100, 500; 500mg—100

Ery-tab Indications

Indications

Susceptible infections including upper and lower respiratory, skin and soft tissue, genitourinary, Legionnaires' disease, pertussis, listeriosis.

Ery-tab Dosage and Administration

Adult

250mg every 6 hours, 500mg every 12 hours, or 333mg every 8 hours; max 4g/day; twice daily dosing max 1g/day. Legionnaires: 1–4g/day in divided doses.

Children

30–50mg/kg/day in divided doses; max 100mg/kg/day.

Ery-tab Contraindications

Contraindications

Concomitant cisapride, pimozide.

Ery-tab Boxed Warnings

Not Applicable

Ery-tab Warnings/Precautions

Warnings/Precautions

Hepatic dysfunction. Myasthenia gravis. Pregnancy (Cat.B). Nursing mothers.

Ery-tab Pharmacokinetics

See Literature

Ery-tab Interactions

Interactions

See Contraindications. May potentiate or be potentiated by drugs metabolized by CYP450 (eg, carbamazepine, cyclosporine, tacrolimus, hexobarbital, phenytoin, alfentanil, disopyramide, bromocriptine, valproate). May potentiate warfarin, triazolam, midazolam, methylprednisolone, digoxin, theophylline, ergotamine. Avoid use with statins (rhabdomyolysis).

Ery-tab Adverse Reactions

Adverse Reactions

GI upset, abdominal pain, anorexia, hepatic dysfunction, rash, superinfection; pseudomembranous colitis, (rare).

Ery-tab Clinical Trials

See Literature

Ery-tab Note

Not Applicable

Ery-tab Patient Counseling

See Literature